MD-TISSUE

INJECTION SOLUTION (STERILE VIALS)

Composition:
Active ingredient: Collagen of porcine origin (2 ml vial).
Ancillary substances: Ascorbic acid, Magnesium gluconate, Sodium chloride, Water for injection.

Indications:
• MD-TISSUE is a medical device designed to help movement by counteracting the physiological ageing of the connective tissue. Its main therapeutic functions include: a barrier effect, a lubricating action, mechanical support while administering other pharmacological treatments. In particular, it:
• Acts as a defensive barrier against free radicals.
• Counteracts the physiological ageing of the connective tissue.
• Soothes local pain caused by movement.
• Due to its special function, MD-TISSUE is also intended to limit the physiological deterioration of the skin and subcutaneous connective tissue, and counterbalance the effects of chrono-ageing and photo-ageing, such as: local anti-ageing treatment, face and neck wrinkles, firming of the subcutaneous and perivascular connective layer of the For this purpose the use of the following materials and face and neck, alteration of the trophicity of the connective accessories is recommended: tissue of face and neck induced by airborne pollutants / • Materials for aseptic skin preparation: single-use gloves, iodine metabolic disorders. solution, alcohol solution, sterile gauze pads, ethyl chloride spray for the skin.

Dosage:
• Needles for microinjections: sterile 27 G, 4 mm.
• Needles for tunnelling injection technique: sterile 30 G, 13 mm. Therapeutic protocol:2 treatments weekly for the first 2 weeks, • Syringes: 5 or 10 cc size, according to the volume of the solution 1 treatment weekly until improvement of symptoms (average to inject. 8-10 sessions). It is possible to go on with 1 treatment every

Package sizes:
Box of 10 sterile vials (2 ml each).

Clinical notes & Combinations:
other week for 10 weeks at most. For chronic pathologies:
go on with 1 treatment weekly for 1 month until improvement
MD-TISSUE may be used as a single treatment or mixed with
of symptoms, then 1 treatment monthly.
other medical devices of the same range, in order to make a
Intradermal injection technique:
customised treatment according to clinical evolution.
The site of application must be aseptic;
Microinjections:
Concerning its use for the treatment of face and neck wrinkles,
Insert the needle at 1-3 mm depth, and inject 0.2-0.3 ml into
and for firming the subcutaneous connective tissue layer, MDthe affected tissue.
TISSUE should preferably be associated with MD-MATRIX
Tunnelling injection technique:
(e.g. MD-TISSUE 2 vials, MD-MATRIX 1 vial / treatment).
inject 0.3 ml per wrinkle. Insert the needle beneath the skin
the full length of the needle, cannulate the wrinkle by moving
It can be used when patients need a supplementation of
the needle gently to left and right, while injecting the content
collagen or a topical antiaging treatment.
of the syringe as the needle is withdrawn.
Periarticular injection technique:
The site of application must be aseptic; insert the needle
perpendicular to the skin surface at 2-4 mm depth, and
perform microinjections of 0.3-0.5 ml.

Product Link: https://urenus.com/en-us/products/md-tissue-pack-of-10-ampoules-of-2ml